Currently out of the existing stock ratings of Caroline Palomeque, 4 are a BUY (100%).

Caroline Palomeque

Work Performance Price Targets & Ratings Chart

Analyst Caroline Palomeque works with a stock forecast success ratio of 25% fulfilled within 452 days on average.

Caroline Palomeque’s has documented 7 price targets and ratings displayed on 2 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on AVXL, Anavex Life Sciences Corp at 23-Jun-2022.

Wall Street Analyst Caroline Palomeque

Analyst best performing recommendations are on AVXL (ANAVEX LIFE SCIENCES CORP).
The best stock recommendation documented was for AVXL (ANAVEX LIFE SCIENCES CORP) at 5/16/2018. The price target of $7 was fulfilled within 904 days with a profit of $4.56 (186.89%) receiving and performance score of 2.07.

Average potential price target upside

AVXL Anavex Life Sciences Corp DARE Dare Bioscience

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

3 months 8 days ago

4/8 (50%)

$38.89 (350.05%)

155

Buy

28

$23.61 (537.81%)

35

1 years 2 months 3 days ago

0/2 (0%)

$17.59 (168.97%)

Hold

11

$6.61 (150.57%)

16

1 years 4 months 6 days ago

4/7 (57.14%)

$2.62 (31.26%)

134

Buy

40

$35.61 (811.16%)

7

1 years 9 months 20 days ago

1/2 (50%)

$29.55 (282.78%)

904

Buy

35

$30.61 (697.27%)

19

2 years 9 months 22 days ago

6/7 (85.71%)

$9.83 (39.05%)

1278

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Caroline Palomeque?

On 2018

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?